tiprankstipranks
Trending News
More News >
ONO Pharmaceutical Co Ltd (JP:4528)
:4528
Japanese Market

ONO Pharmaceutical Co (4528) Ratios

Compare
1 Followers

ONO Pharmaceutical Co Ratios

JP:4528's free cash flow for Q3 2024 was ¥0.66. For the 2024 fiscal year, JP:4528's free cash flow was decreased by ¥ and operating cash flow was ¥0.11. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
3.99 2.81 4.27 2.64 2.47
Quick Ratio
3.52 2.44 3.63 2.22 2.11
Cash Ratio
1.60 0.78 1.05 0.65 0.76
Solvency Ratio
1.27 0.97 1.27 0.86 0.70
Operating Cash Flow Ratio
1.07 1.30 0.94 0.79 0.81
Short-Term Operating Cash Flow Coverage
0.00 -14.44 1.67 -2.65 -2.19
Net Current Asset Value
¥ 298.53B¥ 210.48B¥ 203.74B¥ 141.96B¥ 119.80B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.01 0.01 0.01 0.01
Debt-to-Equity Ratio
0.01 0.01 0.01 0.01 0.01
Debt-to-Capital Ratio
0.01 0.01 0.01 0.01 0.01
Long-Term Debt-to-Capital Ratio
0.00 >-0.01 >-0.01 0.00 -0.01
Financial Leverage Ratio
1.15 1.19 1.13 1.18 1.20
Debt Service Coverage Ratio
638.79 -13.50 2.76 -3.21 -2.25
Interest Coverage Ratio
712.24 155.49 118.07 717.74 91.71
Debt to Market Cap
0.00 -0.01 0.02 -0.02 -0.03
Interest Debt Per Share
18.94 20.65 19.49 18.41 18.27
Net Debt to EBITDA
-0.86 -0.52 -0.47 -0.45 -0.65
Profitability Margins
Gross Profit Margin
74.71%75.39%74.12%72.33%72.96%
EBIT Margin
32.62%32.30%29.31%32.66%27.29%
EBITDA Margin
36.20%37.46%35.57%37.03%32.14%
Operating Profit Margin
32.45%31.75%28.56%31.79%26.50%
Pretax Profit Margin
32.57%32.10%29.06%32.62%27.25%
Net Profit Margin
25.46%25.21%22.28%24.39%20.42%
Continuous Operations Profit Margin
25.47%25.25%22.33%24.41%20.48%
Net Income Per EBT
78.16%78.54%76.67%74.76%74.91%
EBT Per EBIT
100.39%101.11%101.77%102.60%102.85%
Return on Assets (ROA)
14.01%12.77%10.89%10.10%8.87%
Return on Equity (ROE)
16.14%15.19%12.28%11.87%10.61%
Return on Capital Employed (ROCE)
20.14%18.69%15.33%15.06%13.31%
Return on Invested Capital (ROIC)
15.70%14.87%11.13%11.73%10.58%
Return on Tangible Assets
14.94%13.86%11.94%11.15%9.84%
Earnings Yield
10.80%8.35%5.29%5.23%4.77%
Efficiency Ratios
Receivables Turnover
3.69 3.91 3.62 3.67 3.81
Payables Turnover
2.09 13.70 10.40 11.20 12.36
Inventory Turnover
2.61 2.46 2.24 2.19 2.40
Fixed Asset Turnover
4.80 4.12 3.22 2.72 2.55
Asset Turnover
0.55 0.51 0.49 0.41 0.43
Working Capital Turnover Ratio
1.89 2.04 1.96 2.15 2.38
Cash Conversion Cycle
64.17 215.35 228.92 233.86 218.29
Days of Sales Outstanding
98.80 93.37 100.79 99.45 95.90
Days of Inventory Outstanding
139.62 148.62 163.22 166.99 151.91
Days of Payables Outstanding
174.25 26.64 35.09 32.59 29.53
Operating Cycle
238.42 241.99 264.02 266.44 247.82
Cash Flow Ratios
Operating Cash Flow Per Share
230.54 326.87 124.54 148.21 147.14
Free Cash Flow Per Share
187.14 297.18 99.81 107.55 102.61
CapEx Per Share
43.39 29.69 24.73 40.66 44.54
Free Cash Flow to Operating Cash Flow
0.81 0.91 0.80 0.73 0.70
Dividend Paid and CapEx Coverage Ratio
1.91 3.61 1.55 1.73 1.64
Capital Expenditure Coverage Ratio
5.31 11.01 5.04 3.65 3.30
Operating Cash Flow Coverage Ratio
12.49 17.41 7.02 8.17 8.87
Operating Cash Flow to Sales Ratio
0.22 0.36 0.17 0.24 0.25
Free Cash Flow Yield
7.58%10.75%3.26%3.72%4.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
9.26 11.97 18.90 19.13 20.98
Price-to-Sales (P/S) Ratio
2.36 3.02 4.21 4.66 4.28
Price-to-Book (P/B) Ratio
1.49 1.82 2.32 2.27 2.23
Price-to-Free Cash Flow (P/FCF) Ratio
13.19 9.30 30.72 26.87 24.23
Price-to-Operating Cash Flow Ratio
10.71 8.46 24.62 19.50 16.89
Price-to-Earnings Growth (PEG) Ratio
0.60 0.28 2.58 0.69 1.15
Price-to-Fair Value
1.49 1.82 2.32 2.27 2.23
Enterprise Value Multiple
5.65 7.54 11.37 12.14 12.68
Enterprise Value
1.03T 1.26T 1.46T 1.39T 1.19T
EV to EBITDA
5.65 7.54 11.37 12.14 12.68
EV to Sales
2.04 2.82 4.05 4.50 4.08
EV to Free Cash Flow
11.44 8.70 29.50 25.90 23.06
EV to Operating Cash Flow
9.29 7.91 23.64 18.80 16.08
Tangible Book Value Per Share
1.54K 1.39K 1.20K 1.14K 995.26
Shareholders’ Equity Per Share
1.65K 1.52K 1.32K 1.27K 1.12K
Tax and Other Ratios
Effective Tax Rate
0.22 0.21 0.23 0.25 0.25
Revenue Per Share
1.05K 915.80 727.88 619.64 580.23
Net Income Per Share
266.61 230.85 162.19 151.11 118.47
Tax Burden
0.78 0.79 0.77 0.75 0.75
Interest Burden
1.00 0.99 0.99 1.00 1.00
Research & Development to Revenue
0.22 0.21 0.21 0.20 0.23
SG&A to Revenue
0.20 0.20 0.21 0.22 0.23
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.86 1.11 0.59 0.73 0.93
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis